Haemonetics Corp. HAE

NYS: HAE | ISIN: US4050241003   12/12/2025
83,49 USD (-1,14%)
(-1,14%)   12/12/2025

6 november 2025 · Haemonetics Corporation Announces Second Quarter Fiscal 2026 Financial Results Available on Investor Relations Website · Persbericht

9 oktober 2025 · Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2026 Results: November 6, 2025 · Persbericht

7 augustus 2025 · Haemonetics 1st Quarter Fiscal Year 2026 Earnings Release Available on Investor Relations Website · Persbericht

9 juli 2025 · Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2026 Results: August 7, 2025 · Persbericht

30 mei 2025 · Haemonetics to Present at Goldman Sachs 46th Annual Global Healthcare Conference · Persbericht

8 mei 2025 · Haemonetics 4th Quarter and Fiscal Year 2025 Earnings Release Available on Investor Relations Website · Persbericht

31 maart 2025 · Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2025 Results: May 8, 2025 · Persbericht

3 maart 2025 · Haemonetics Announces Executive Leadership Updates · Persbericht

15 augustus 2024 · Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System · Persbericht

8 augustus 2024 · Haemonetics 1st Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website · Persbericht

30 juli 2024 · Haemonetics Announces CE Mark Certification for the SavvyWire® Pre-Shaped Pressure Guidewire · Persbericht

8 juli 2024 · Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2025 Results: August 8, 2024 · Persbericht

18 juni 2024 · Haemonetics Launches Limited Market Release for New VASCADE MVP XL Vascular Closure Device · Persbericht

23 mei 2024 · Haemonetics Prices Upsized Private Placement of $600 Million Convertible Senior Notes · Persbericht

21 mei 2024 · Haemonetics Announces Proposed Convertible Senior Notes Offering · Persbericht

9 mei 2024 · Haemonetics 4th Quarter and Fiscal Year 2024 Earnings Release Available on Investor Relations Website · Persbericht

10 april 2024 · Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024 · Persbericht

4 april 2024 · Haemonetics Receives FDA Clearance for New TEG® 6s Global Hemostasis - HN Cartridge · Persbericht

1 april 2024 · Haemonetics Corporation Completes Acquisition of Attune Medical · Persbericht

5 maart 2024 · Haemonetics Announces Definitive Agreement to Acquire Attune Medical · Persbericht

Mijn selecties